Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) (Middle Region) Antikörper
Kurzübersicht für Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) (Middle Region) Antikörper (ABIN5517860)
Target
Alle Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) ProdukteReaktivität
Wirt
Klonalität
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- GSVSCCGNAN FSGSVTGGGS GGSCWGGSSV ERSERRKRRS TDSSSVSGSL
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human CAAP1
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 23 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Caspase Activity and Apoptosis Inhibitor 1 (CAAP1)
-
Andere Bezeichnung
- CAAP1
-
Hintergrund
-
Alias Symbols: CAAP, C9orf82
Protein Size: 361 -
Gen-ID
- 79886
-
NCBI Accession
- NM_001167575, NP_001161047
-
UniProt
- Q9H8G2
Target
-